The place of methotrexate perioperatively in elective orthopedic surgeries in patients with rheumatoid arthritis
Tóm tắt
No clear consensus exists on whether methotrexate (MTX) should be continued or whether this therapy should be discontinued for a few weeks in patients with rheumatoid arthritis (RA) undergoing surgery. Continued MTX therapy may impair wound healing, but discontinuation of the therapy may increase the risk of flares. In this article we review published data on the perioperative management of MTX in patients with RA undergoing elective orthopedic surgery. Eight papers on this topic could be identified. These studies compare continued vs. discontinued MTX therapy or MTX therapy vs. therapies other than MTX. Summing up the published data, continued MTX therapy appears to be safe perioperatively and seems also to be associated with a reduced risk of flares. None of the examined papers addresses the issue of safety in connection with comorbidities, age or high doses of MTX.
Tài liệu tham khảo
Williams HJ, Willkens RF, Samuelson CO Jr, Alarcon GS, Guttadauria M, Yarboro C, Polisson RP, Weiner SR, Luggen ME, Billingsley LM et al (1985) Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis Rheum 28:721–730
Weinblatt ME, Polisson R, Blotner SD, Sosman JL, Aliabadi P, Baker N, Weissman BN (1993) The effects of drug therapy on radiographic progression of rheumatoid arthritis. Results of a 36-week randomized trial comparing methotrexate and auranofin. Arthritis Rheum 36:1028–1034
Furst DE (1997) The rational use of methotrexate in rheumatoid arthritis and other rheumatic diseases. Brit J Rheum 36:1196–1204
Karukonda SR, Flynn TC, Boh EE, McBurney EI, Russo GG, Millikan LE (2000) The effects of drugs on wound healing–part II. Specific classes of drugs and their effect on healing wounds. Int J Dermatol 39:321–333
Steuer A, Keat AC (1997) Perioperative use of methotrexate—a survey of clinical practice in the UK. Br J Rheumatol 36:1009–1011
Bridges SL, Lopez-Mendez A, Han KH, Tracy IC, Alarcon GS (1991) Should methotrexate be discontinued before elective orthopaedic surgery in patients with rheumatoid arthritis. J Rheumatol 18:984–988
Perhala RS, Wilke WS, Clough JD, Segal AM (1991) Local infectious complications following large joint replacement in rheumatoid arthritis patients treated with methotrexate versus those not treated with methotrexate. Arthritis Rheum 34:146–152
Kasdan ML, June L (1993) Postoperative results of rheumatoid arthritis patients on methotrexate at the time of reconstructive surgery of the hand. Orthopedics 16:1233–1235
Jain A, Witbreuk M, Ball C, Nanchahal J (2002) Influence of steroids and methotrexate on wound complications after elective rheumatoid hand and wrist surgery. J Hand Surg [Am] 27:449–455
Murata K, Yasuda T, Ito H, Yoshida M, Shimizu M, Nakamura T (2006) Lack of increase in postoperative complications with low-dose methotrexate therapy in patients with rheumatoid arthritis undergoing elective orthopedic surgery. Mod Rheumatol 16:14–19
Sany J, Anaya JM, Canovas F, Combe B, Jorgensen C, Saker S et al (1993) Influence of methotrexate on the frequency of postoperative infectious complications in patients with rheumatoid arthritis. J Rheumatol 20:1129–1132
Carpenter MT, West SG, Vogelgesang SA, Casey Jones DE (1996) Postoperative joint infections in rheumatoid arthritis patients on methotrexate therapy. Orthopedics 19:207–210
Grennan DM, Gray J, Loudon J, Fear S (2001) Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Ann Rheum Dis 60:214–217
Garner RW, Mowar AG, Hazelman BL (1973) Post-operative wound healing in patients with rheumatoid arthritis. Ann Rheum Dis 32:273–274
van der Veen MJ, van der Heide A, Kruize AA, Bijlsma JW (1994) Infection rate and use of antibiotics in patients with rheumatoid arthritis treated with methotrexate. Ann Rheum Dis 53:224–228
Cohen SC, Gabelnick HL, Johnson RK, Goldin A (1975) Effects of antineoplastic agents on wound healing in mice. Surgery 78:238–244
Bridges SL Jr, Moreland LW (1997) Perioperative use of methotrexate in patients with rheumatoid arthritis undergoing orthopedic surgery. Rheum Dis Clin North Am 23:981–993
Kremer JM, Rynes RI, Bartholomew LE (1987) Severe flare of rheumatoid arthritis after discontinuation of long-term methotrexate therapy. Double-blind study. Am J Med 82:781–788
Delank KS, Hansen T, Eysel P, Eckardt A (2002) Infektionen des Bewegungsapparates bei der chronischen Polyarthritis während einer Kombinationstherapie mit Methotrexat und Leflunomid. Z Orthop Ihre Grenzgeb 140:555–560
Gutierrez-Urena S, Molina JF, Garcia CO, Cuellar ML, Espinoza LR (1996) Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis. Arthritis Rheum 39:272–276
Hoekstra M, Haagsma C, Neef C, Proost J, Knuif A, van de Laar M (2004) Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis. J Rheumatol 31:645–648